TRELLUS HEALTH PLC (TRLS) — Investor Presentation

Investor webinar replay

Replay transcript excerpt

Good afternoon, ladies and gentlemen. Welcome to the TRLS Health Interim Results Investor Presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged. They can be submitted at any time using the Q and A tab The company may not be in a position to answer every question it receives during the meeting itself. However, the company can review your questions submitted today, and we'll publish those responses on the Investor Meet company platform. Before we begin, we'd like to submit the following poll, and I'm sure the company would be most grateful for your participation. I'd now like to hand over to cofounder and CEO, doctor Marla Dubinsky. Good afternoon. Wonderful. Good afternoon, and thank you everybody for attending attending this meeting. And I'm delighted to be presenting our interim results for the period ended 06/30/2023. And accompanying me today is our new CFO, Joy Besinger, who I'm delighted to be part of the exec team. And, we're here today to, update you on where we are. Alright. So here we have the disclaimer, and let's move directly into a company overview. So, you know, we've met for those of you we've met before, hello again. Those that we haven't met, we're excited to share with you an overview of TRLS, just a reminder of sort of what our focus is and what our key assets are. So we're a digital health company, first focusing in GI chronic condition management. We're really focused on those individuals who have chronic incurable physical GI conditions and the overlap in those who have a comorbid mental health condition, which accompanies a lot of patients, unfortunately, who are diagnosed young, and need chronic condition management and and, medication. And there's a high mental health burden that ...